<DOC>
	<DOC>NCT00200109</DOC>
	<brief_summary>Background: Medically intractable chronic migraine (CM) is a disabling illness characterized by headache greater than 15 days per month. Method: A multicenter, randomized, blinded, controlled feasibility study was conducted to obtain preliminary safety and efficacy data on occipital nerve stimulation (ONS) in CM. Eligible subjects received an occipital nerve block, and responsers were randomized to adjustable stimulation (AS), preset stimulation (PS) or medical management (MM) groups.</brief_summary>
	<brief_title>Occipital Nerve Stimulation for the Treatment of Chronic Migraine Headache.</brief_title>
	<detailed_description>The therapy under investigation involves a Medtronic neurostimulation device which delivers electrical impulses via insulated lead wires placed under the skin near the occipital nerves at the base of the head.</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Diagnosis of Chronic Migraine Headache by International Headache Society (IHS) criteria compliance with daily questionnaire headache that has not responded to at least two classes of headache medications stable headache medication regimen previous surgical procedures to disrupt the nerves of the neck relating to the headache subjects who may require MRI or Diathermy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>